Koninklijke Philips マネジメント

マネジメント基準チェック /34

Koninklijke Philipsの CEO はRoy Jakobsで、 Oct2020年に任命され、の在任期間は 4.08年です。の年間総報酬は€ 4.58Mで、 26.2%給与と73.8%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.014%を直接所有しており、その価値は€ 3.30M 。経営陣と取締役会の平均在任期間はそれぞれ5.3年と4.6年です。

主要情報

Roy Jakobs

最高経営責任者

€4.6m

報酬総額

CEO給与比率	26.2%
CEO在任期間	4.1yrs
CEOの所有権	0.01%
経営陣の平均在職期間	5.3yrs
取締役会の平均在任期間	4.6yrs

経営陣の近況

Recent updates

CEO報酬分析

Koninklijke Philips の収益と比較して、Roy Jakobs の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	-€469m
Jun 30 2024	n/a	n/a	-€555m
Mar 31 2024	n/a	n/a	-€794m
Dec 31 2023	€5m	€1m	-€456m
Sep 30 2023	n/a	n/a	-€609m
Jun 30 2023	n/a	n/a	-€2b
Mar 31 2023	n/a	n/a	-€2b
Dec 31 2022	€1m	€256k	-€2b

報酬と市場: Royの総報酬 ($USD 4.82M ) は、 German市場 ($USD 4.83M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Royの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Roy Jakobs (50 yo)

4.1yrs

在職期間

€4,582,347

報酬

Mr. Roy Jakobs serves as its Chief Executive Officer & President since October 15, 2022. He serves as Chairman of the Board of Management at Koninklijke Philips N.V. since October 2022. He served as Execut...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Roy Jakobs	President	4.1yrs	€4.58m	0.014% € 3.3m
Paulus Stoffels	Independent Vice Chairman of Supervisory Board & Secretary	no data	€172.27k	0.0020% € 452.1k
Marnix van Ginneken	Executive VP	10.5yrs	€2.30m	0.015% € 3.4m
Charlotte Hanneman	Executive VP	less than a year	データなし	データなし
Willem Appelo	Executive VP & COO	2.1yrs	データなし	データなし
Leandro Mazzoni	Head of Investor Relations	5.3yrs	データなし	データなし
Heidi Sichien	Executive VP & Chief People Officer	1.3yrs	データなし	データなし
Jan Kimpen	Chief Medical Officer	8.8yrs	データなし	データなし
Pim Preesman	Country Leader/ Health Systems Leader Indonesia	5.3yrs	データなし	データなし
Henk de Jong	Executive VP & CEO of Domestic Appliances	7.6yrs	データなし	データなし
Bert van Meurs	Executive VP and Chief Business Leader Image Guided Therapy & Precision Diagnosis (ad interim))	5.8yrs	データなし	データなし
Deeptha Khanna	Executive VP & Chief Business Leader of Personal Health Businesses	4.3yrs	データなし	データなし

5.3yrs

平均在職期間

60yo

平均年齢

経験豊富な経営陣: PHI1の経営陣は経験豊富で経験豊富です（平均在職期間は5.3年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Paulus Stoffels	Independent Vice Chairman of Supervisory Board & Secretary	6.3yrs	€172.27k	0.0020% € 452.1k
Indra Nooyi	Independent Member of Supervisory Board	3.5yrs	€131.27k	0.00036% € 82.6k
David E. Pyott	Independent Member of Supervisory Board	9.5yrs	€154.77k	0.0022% € 504.9k
Feike Sijbesma	Independent Chairman of Supervisory Board	4.6yrs	€206.35k	0.0028% € 635.7k
Peter Loscher	Independent Member of Supervisory Board	4.6yrs	€149.27k	0.0024% € 550.8k
Sock Koong Chua	Independent Member of the Supervisory Board	3.5yrs	€140.27k	0.00023% € 52.8k
Sanjay Poonen	Independent Member of Supervisory Board	2.5yrs	€137.77k	0.00035% € 80.3k
Hendrika W. P. M. Verhagen	Independent Member of Supervisory Board	2.5yrs	€121.27k	データなし
Benoit Ribadeau-Dumas	Member of the Supervisory Board	less than a year	データなし	データなし
A. Harrison	Independent Member of Supervisory Board	6.1yrs	€133.77k	0.00017% € 39.0k
Elizabeth Doherty	Independent Member of Supervisory Board	5.5yrs	€154.27k	データなし

4.6yrs

平均在職期間

65yo

平均年齢

経験豊富なボード: PHI1の取締役会は経験豊富であると考えられます ( 4.6年の平均在任期間)。

Koninklijke Philips マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Philips Announces Managing Director Changes for the Philips Indian Subcontinent

Recent updates

Third quarter 2024 earnings released: EPS: €0.19 (vs €0.10 in 3Q 2023)

Royal Philips Announces the Launch of the New Philips Avent Premium Connected Baby Monitor

Philips Announces Managing Director Changes for the Philips Indian Subcontinent

Koninklijke Philips N.V. (ENXTAM:PHIA) announces an Equity Buyback for €125 million worth of its shares.

New major risk - Financial position

Second quarter 2024 earnings released: EPS: €0.33 (vs €0.078 in 2Q 2023)

Royal Philips Zenition 90 Motorized Receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm

Philips Launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

New minor risk - Shareholder dilution

First quarter 2024 earnings released: €1.10 loss per share (vs €0.72 loss in 1Q 2023)

Full year 2023 earnings released: €0.50 loss per share (vs €1.76 loss in FY 2022)

Koninklijke Philips N.V. to Report Q4, 2024 Results on Feb 03, 2025

Royal Philips Announces New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

Full year 2023 earnings released: €0.50 loss per share (vs €1.84 loss in FY 2022)

Koninklijke Philips N.V. Provides Earnings Guidance for the Year 2024

Royal Philip Introduces the Latest Offering in the Philips Norelco Oneblade Lineup

Angeion Group Announces Proposed Settlement in Re Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation Class Action

Angeion Group Announces Proposed Settlement in In Re Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation Class Action

Koninklijke Philips N.V. to Report Q2, 2024 Results on Jul 29, 2024

Royal Philips Launches Ultra Lightweight and Flexible MR Smart Fit Coels to Improve Radiology Productivity and Diagnostic confidence at #RSNA23

Koninklijke Philips N.V. Improves Workflow and Efficiency with Next Generation Ultrasound Systems EPIQ Elite and Affiniti at RSNA23

Philips Launches New-AI Enabled Innovations at #RSNA23 That Free Up Healthcare Providers to Focus on Patient Care

Royal Philips Announces Latest Results Demonstrating the Safety of Philips Instant Wave-Free Ratio (iFR) in the Guidance of PCI

Koninklijke Philips N.V. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: €0.10 (vs €1.50 loss in 3Q 2022)

Royal Philips and US Subsidiaries Including Philips Respironics Reach an Agreement to Resolve All Economic Loss Claims in the US Multidistrict Litigation

Exor N.V. (ENXTAM:EXO) acquired 15% stake in Koninklijke Philips N.V. (ENXTAM:PHIA).

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /34